Protean Ltd. is a ISO 9001 & ISO 13485 certified CRO focused on the R&D of innovative pathogen diagnostics and the production of artificial and native recombinant proteins. We produce antigens from wild type Borrelia strains for the development of new generation IVD tests for the Lyme disease diagnostics. We are focused on the development of fast in vitro evolution technology for production of high affinity protein binders. Our Vision We believe that using advanced technologies, the near endless amino acid sequence space could be exploited for construction of novel proteins with any imaginable properties.